What is Tunlametinib used for?

Tunlametinib is being researched for the treatment of cancers such as melanoma, non-small cell lung carcinoma, and colorectal carcinoma.

Is Tunlametinib approved for melanoma?

It is currently being studied in clinical trials for melanoma, but approval status is not provided in this data.

Can Tunlametinib treat lung cancer?

The drug is being investigated for use in patients with non-small cell lung carcinoma.

What kind of drug is Tunlametinib?

Tunlametinib is classified as a small molecule drug.

Is Tunlametinib safe for children?

There is no information available regarding the use of Tunlametinib in pediatric patients.

Are there known side effects for Tunlametinib?

The provided data does not list specific side effects for Tunlametinib.

Tunlametinib | CAS 1801756-06-8 | UFZJUVFSSINETF

Loading compound...

Small molecule inhibitor

Tunlametinib is a small molecule drug currently being studied in clinical trials for various types of cancer, including melanoma and non-small cell lung carcinoma.

Used for

MelanomaNon-small cell lung carcinomaColorectal carcinomaOther neoplasms

Conditions

MelanomaNon-small cell lung carcinomaColorectal carcinomaNeoplasm

Class

Small moleculeSmall molecule inhibitor

How to take

Information on how to take this medication is not available in the provided data.

Talk to your doctor

Questions to ask

·Is Tunlametinib appropriate for my type of cancer?
·What are the potential risks of Tunlametinib?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)